Record #34806

Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma

Original paper date
May 18, 2020
Institution
Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada · Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA · Department of Pediatrics, Northwestern University, Chicago, IL, USA · Division of Haematology/Oncology and Department of Paediatrics, Hospital for Sick Children, Toronto, Canada · Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada · Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom · Brain Tumor Program, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA · Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children’s Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, IL, USA · Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA · Departments of Pediatrics and Neurosciences, University of California, San Diego – Rady Children’s Hospital, San Diego, CA, USA · Department of Neurosurgery, University of California San Diego – Rady Children’s Hospital, San Diego, CA, USA · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA · Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
Open access
No
Article type
Citation lifecycle

How this paper is being cited

Pre-retraction
17
Same day
0
Post-retraction
24
% post-retraction
58.5%
~10.8 citations/yr before retraction · ~5.0 citations/yr after
citing papers

Who is still citing this work

Loading…